This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders APAC
New Data, Case Studies & Partners
October 15-16, 2025Marina Bay Sands, Singapore

Mr Long-Cheng Li
President & CEO at Ractigen Therapeutics
Speaker

Profile

Dr. Long-Cheng Li is the founder, President, and CEO of Ractigen Therapeutics. He is globally recognized for his pioneering work on RNA-mediated gene activation (RNAa), a technology he has advanced from a discovery into the clinical stage. Before founding Ractigen in 2017, he was an Associate Professor at the University of California, San Francisco (UCSF) and a professor at Peking Union Medical College Hospital. He has authored or co-authored over 80 publications with more than 14,000 citations, and received multiple research grants, including the NIH Director’s Transformative R01 Award. He is a frequent invited speaker at conferences, universities, and companies worldwide.

Agenda Sessions

  • RNAa - The Dawn of a New Therapeutic Era

    2:00pm